JP2013503170A5 - - Google Patents

Download PDF

Info

Publication number
JP2013503170A5
JP2013503170A5 JP2012526933A JP2012526933A JP2013503170A5 JP 2013503170 A5 JP2013503170 A5 JP 2013503170A5 JP 2012526933 A JP2012526933 A JP 2012526933A JP 2012526933 A JP2012526933 A JP 2012526933A JP 2013503170 A5 JP2013503170 A5 JP 2013503170A5
Authority
JP
Japan
Prior art keywords
phenyl
oxy
trifluoromethyl
pyrimidinyl
methylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012526933A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013503170A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/046564 external-priority patent/WO2011025798A1/en
Publication of JP2013503170A publication Critical patent/JP2013503170A/ja
Publication of JP2013503170A5 publication Critical patent/JP2013503170A5/ja
Pending legal-status Critical Current

Links

JP2012526933A 2009-08-28 2010-08-25 化合物および方法 Pending JP2013503170A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23781509P 2009-08-28 2009-08-28
US61/237,815 2009-08-28
PCT/US2010/046564 WO2011025798A1 (en) 2009-08-28 2010-08-25 Compounds and methods

Publications (2)

Publication Number Publication Date
JP2013503170A JP2013503170A (ja) 2013-01-31
JP2013503170A5 true JP2013503170A5 (enExample) 2013-10-10

Family

ID=43628352

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012526933A Pending JP2013503170A (ja) 2009-08-28 2010-08-25 化合物および方法

Country Status (4)

Country Link
US (1) US20120157482A1 (enExample)
EP (1) EP2470022A4 (enExample)
JP (1) JP2013503170A (enExample)
WO (1) WO2011025798A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019119486A1 (zh) * 2017-12-21 2019-06-27 中国科学院合肥物质科学研究院 一类嘧啶类衍生物激酶抑制剂
CN110698352B (zh) * 2019-10-29 2023-01-17 邢台学院 一种3-溴-5-氨基邻苯二酚二甲醚的合成方法
GB202006382D0 (en) 2020-04-30 2020-06-17 Spermatech As Use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7517880B2 (en) * 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
EP1042305B1 (en) * 1997-12-22 2005-06-08 Bayer Pharmaceuticals Corp. INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
DE1049664T1 (de) * 1997-12-22 2001-05-03 Bayer Corp., Pittsburgh Hemmung der raf-kinase unter verwendung von symmetrisch und unsymmetrisch substituierten harnstoffen
PE20040522A1 (es) * 2002-05-29 2004-09-28 Novartis Ag Derivados de diarilurea dependientes de la cinasa de proteina
US7459562B2 (en) * 2004-04-23 2008-12-02 Bristol-Myers Squibb Company Monocyclic heterocycles as kinase inhibitors
JP5124812B2 (ja) * 2004-11-24 2013-01-23 国立大学法人 熊本大学 Ｍａｐキナーゼｔｎｎｉ３ｋを用いた心疾患治療剤
GB0500435D0 (en) * 2005-01-10 2005-02-16 Novartis Ag Organic compounds
CA2672718A1 (en) * 2006-12-22 2008-07-03 F. Hoffmann-La Roche Ag Pyrimidyl derivatives as protein kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2010523692A5 (enExample)
JP2014528403A5 (enExample)
JP2010501587A5 (enExample)
JP2016500661A5 (enExample)
JP2019529490A5 (enExample)
JP2009525956A5 (enExample)
JP2014523901A5 (enExample)
JP2010526025A5 (enExample)
JP2018535967A5 (enExample)
SI2303270T1 (en) Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceutical products
JP2012530705A5 (enExample)
JP2013537203A5 (enExample)
JP2013526494A5 (enExample)
JP2010528089A5 (enExample)
JP2004504301A5 (enExample)
JP2008546791A5 (enExample)
JP2007523155A5 (enExample)
JP2013523803A5 (enExample)
JP2018522823A5 (enExample)
JP2008523069A5 (enExample)
JP2010532386A5 (enExample)
JP2012507535A5 (enExample)
JP2012255002A5 (enExample)
JP2014502979A5 (enExample)
RU2012158142A (ru) Противоопухолевое средство, задействующее соединения с ингибирующим эффектом к киназам в комбинации